.png)
Taliaz
PREDICTIX — AI clinical decision-support for mental health: antidepressant selection (pharmacogenetic) + triage/care management
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Taliaz appears to be a niche Israeli/UK health-tech company focused on AI-enabled psychiatric decision support and pharmacogenetics, with Predictix positioned for clinician workflow integration and depression treatment optimization.[1][2][7][14] The company shows credible product and market validation signals, but external visibility, scale, and operational depth appear modest relative to a mature commercial health-tech vendor.[10][12][17]
Efficiency Ratio
Taliaz demonstrates relatively strong product sophistication for a small team, suggesting good research-to-product conversion efficiency, but the limited revenue and staffing signals indicate constrained output scaling.[11][12][17]
Evidence Signals
Predictix is described as a CE-registered decision support product for psychiatrists and general practitioners, with availability in the UK and Israel.
Taliaz and Psychiatry UK launched an online service combining artificial intelligence and genetic testing for depression sufferers.
The company is referenced as a supplier with Horizon 2020 experience, indicating participation in EU-funded activity.
Taliaz's AI platform is described as supporting triage, queue management, resource allocation, and quality control in mental health systems.
The company emphasizes patented/proprietary-style scientific data and deep-learning capabilities in personalized medicine for CNS and neuropsychiatric disorders.
Public company profile data indicates a small organizational footprint, with approximately 11-50 employees and headquarters in Israel plus a Leeds, England location.
Third-party business directories estimate annual revenue below $5 million and employee count around 10-19, suggesting an early-scale commercialization stage.
- About
- Israeli behavioral-health AI company (HQ Petah Tikva, Israel; founded ~2015 by neuroscientist brothers Dr. Dekel Taliaz (CEO) and Oren Taliaz). Its PREDICTIX platform is a clinical decision-support tool for mental health: PREDICTIX Antidepressant uses AI over genetic, clinical and demographic data to help clinicians pick the right antidepressant first time (CE-registered; commercial in EU and Israel), and PREDICTIX Care adds AI-driven patient triage, intake, queue/resource management and automated note-taking — cutting mental-health backlog by up to ~75%. Traction includes an Israel Ministry of Health agreement (~$8M) with Maccabi HMO, plus UK (Psychiatry UK) and France (Cerba HealthCare). Defense relevance: the triage/queue-management tooling has been used to cut waiting lists in Israel's trauma centers amid the post-2023 reservist mental-health surge; center of gravity is behavioral-health decision-support software, not a treatment device.
- Tags
- #behavioralhealth #mentalhealth #ai #pharmacogenetics #predictix #decisionsupport #triage #depression #antidepressant #dualuse